Trade Bristol Myers ^BMY

Vanguard Group Inc. Grows Stock Holdings in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Acquired by Chicago Partners Investment Group LLC

Advisors Capital Management LLC Raises Stake in Bristol Myers Squibb Company $BMY

Bristol-Myers Squibb Precision Oncology Deal Meets Mixed Valuation Signals

Pfizer Tests Transparent Eliquis Pricing As Valuation Signals Undervaluation

Pfizer Eliquis Price Move With Cost Plus Raises Questions On Valuation

First Interstate Bank Sells 52,361 Shares of Bristol Myers Squibb Company $BMY

3 Healthcare Stocks That Pay You a Dividend While You Wait for a Recovery

Assessing Bristol Myers Squibb (BMY) Valuation After Recent Earnings Compression And Growth Portfolio Performance

Mantle cell lymphoma outcomes following sequential first-line bendamustine-rituximab and second-line Bruton's tyrosine kinase inhibitor therapy

Bristol Myers, Pfizer Bring Eliquis to Cost Plus at $345 Monthly

Bristol-Myers Squibb Company (BMY): Favorite for Conservative Portfolios

Bristol Myers, Pfizer to offer blockbuster blood thinner through Mark Cuban's online pharmacy

Kerusso Capital Management LLC Purchases 12,988 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

5 Best Defensive Stocks to Invest In Now

HCA Holdings News | Markets Insider

Milestone in Atrium and BMS cardiovascular collaboration | BioWorld

Is It Too Late To Consider Bristol Myers Squibb (BMY) After A 27% One-Year Rally?

Targeted therapies plus radiotherapy for diffuse intrinsic pontine glioma: the randomized phase 2 BIOMEDE trial

Ardelyx Brings In New Legal Chief As Governance Enters Next Phase

OLD National Bancorp IN Sells 19,971 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

BMY Secures $15M Milestone Payment to Atrium Therapeutics

Atrium Therapeutics Earns $15 Million Milestone Payment from Bristol Myers Squibb Under Global Cardiovascular Collaboration | Morningstar

Bristol Myers Squibb (BMY) to Release Quarterly Earnings on Thursday

Milestone Asset Management LLC Buys Shares of 41,725 Bristol Myers Squibb Company $BMY - Daily Political

OVERSEA CHINESE BANKING Corp Ltd Has $1.13 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb Aligns MTAP Precision Oncology Push With Solar Shift

Bristol Myers Squibb Cutting 206 More Jobs - New Jersey Business Magazine

Should You Forget Pfizer and Buy This Pharma Stock Instead?

Bristol Myers Squibb Company $BMY Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Sjogren's Syndrome Market Analysis Report 2025-2035 Featuring Novartis, Otsuka Pharmaceutical, Nicox, and Bristol Myers Squibb

61,789 Shares in Bristol Myers Squibb Company $BMY Bought by CPC Advisors LLC

Pfizer's ASCO Oncology Data Puts Future Cancer Revenue Story In Focus

Is BMY Undervalued? DCF Says Worth $76

Geronimo Power Announces Start of Operations at Blevins Solar | Morningstar

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

Epigenetic fingerprints link early-onset colon and rectal cancer to pesticide exposure

Bristol Myers Squibb (NYSE:BMY) Stock Rating Upgraded by Wall Street Zen - Daily Political

BMY Stock: Analysts See 16% Upside and a Strong Buy

Bristol Myers Squibb Company $BMY Shares Purchased by Krilogy Financial LLC

Zurcher Kantonalbank Zurich Cantonalbank Sells 99,271 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Bristol Myers Squibb (NYSE:BMY) Rating Increased to Strong-Buy at Wall Street Zen - Markets Daily

Bristol Myers Squibb Company $BMY Shares Acquired by Hudson Edge Investment Partners Inc. - Stock Observer

Ciltacabtagene autoleucel in high-risk smoldering multiple myeloma: the CAR-PRISM phase 2 trial

Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial

Moderna's mRNA Melanoma Data And Fast Track Status Shape Oncology Story

First Horizon Corp Sells 25,288 Shares of Bristol Myers Squibb Company $BMY

Research Analysts' Upgrades for April 19th (BMY, CHMG, CXW, DUOT, FTS, GE, GFI, HOFT, IMRX, IQV) - Daily Political

How Investors May Respond To Bristol Myers Squibb (BMY) Expanding T‑Cell Engager Pact With Oxford BioTherapeutics

Wall Street Zen Upgrades Bristol Myers Squibb (NYSE:BMY) to Strong-Buy

Gilead Leans Further Into Oncology With Arcellx And Tubulis Deals

BMY: Pipeline Progress And Sector Shifts Will Shape Future Risk Balance

Bristol-Myers Squibb Collaboration Adds New Dimension To Oncology Valuation Story

Bristol Myers Squibb Company $BMY Shares Purchased by Merit Financial Group LLC

PD-L1 CPS in gastroesophageal cancer: differences in routine care versus Checkmate 649 and implications for biopsy-site choice and assay standardisation

Pharmaceutical Stocks To Follow Now - April 17th - Stock Observer

Bristol Myers Squibb Company $BMY Shares Sold by Mirae Asset Global Investments Co. Ltd.

Beeline Medicines Launches: $300M for Autoimmune Therapies

Parcion Private Wealth LLC Has $1.45 Million Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Lbp Am Sa

Drugmakers raised prices despite Trump deals, report finds - NBC Los Angeles

Cwm LLC Acquires 422,041 Shares of Bristol Myers Squibb Company $BMY

Cwm LLC Has $66.27 Million Stock Holdings in Bristol Myers Squibb Company $BMY - Stock Observer

Is Bristol Myers Squibb (BMY) Pricing Reflecting Its Recent 1 Year 22% Share Gain?

Patten Group Inc. Invests $1.04 Million in Bristol Myers Squibb Company $BMY

Is It Too Late To Reassess Bristol Myers Squibb (BMY) After Its Recent Share Price Rebound

Massachusetts Financial Services Co. MA Increases Stock Position in Bristol Myers Squibb Company $BMY - Stock Observer

FDA Setback For Replimune Opdivo Combo Adds Uncertainty To BMY Outlook

Elraglusib and chemotherapy in metastatic pancreatic ductal adenocarcinoma: a randomized controlled phase 2 trial

Is Bristol-Myers Squibb Company (BMY) Among the 15 Cash-Rich Dividend Stocks to Invest in Right Now

State of Alaska Department of Revenue Sells 59,405 Shares of Bristol Myers Squibb Company $BMY - Markets Daily

State of Alaska Department of Revenue Sells 59,405 Shares of Bristol Myers Squibb Company $BMY - Stock Observer

Here are the 3 big things we're watching in the stock market this week

Bristol Myers Squibb Company $BMY Shares Sold by Robeco Institutional Asset Management B.V.

Ritholtz Wealth Management Boosts Stake in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Company $BMY Shares Sold by Sumitomo Mitsui Trust Group Inc. - Stock Observer

Should BMY's Camzyos Youth Data and T‑Cell Deal Require Action From Bristol Myers (BMY) Investors?

Bristol Myers Squibb Company $BMY Shares Sold by Cantor Fitzgerald Investment Advisors L.P.

Bartlett & CO. Wealth Management LLC Has $7.26 Million Position in Bristol Myers Squibb Company $BMY

Bristol Myers Squibb (NYSE:BMY) Rating Lowered to Buy at Wall Street Zen

Assessing Bristol Myers Squibb (BMY) Valuation After Camzyos Data And T Cell Engager Collaboration News

Replimune (REPL) Stock Plunges 19% Following Second FDA Rejection of Melanoma Treatment

Replimune (REPL) Shares Plunge 19% Following Second FDA Rejection of RP1 Melanoma Treatment

Replimune (REPL) Shares Plunge 19% as FDA Issues Second Rejection for Melanoma Treatment

Douglas Lane & Associates LLC Buys 32,821 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb Cancer Alliance Adds Weight To Valuation Debate

Capital Investment Advisory Services LLC Acquires 18,028 Shares of Bristol Myers Squibb Company $BMY

Bristol Myers Squibb (NYSE:BMY) Price Target Lowered to $67.00 at Bank of America - Stock Observer

Bristol-Myers Likely to Get Desired Court in Paxton Plavix Suit

Bank of America Lowers Bristol Myers Squibb (NYSE:BMY) Price Target to $67.00

Bristol-Myers Squibb Earnings Preview: What to Expect